Overview
Hendrik Stunnenberg practices in Nijmegen, Netherlands. Mr. Stunnenberg is rated as an Experienced expert by MediFind in the treatment of Multiple Myeloma. His top areas of expertise are Androgen Insensitivity Syndrome, Acute Myeloid Leukemia (AML), Leukemia, and Mantle Cell Lymphoma (MCL).
His clinical research consists of co-authoring 209 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Multiple Myeloma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)Mr. Stunnenberg isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Androgen Insensitivity SyndromeMr. Stunnenberg isAdvanced. Learn about Androgen Insensitivity Syndrome.
- LeukemiaMr. Stunnenberg isAdvanced. Learn about Leukemia.
- Experienced
- Acute Promyelocytic LeukemiaMr. Stunnenberg isExperienced. Learn about Acute Promyelocytic Leukemia.
- B-Cell LymphomaMr. Stunnenberg isExperienced. Learn about B-Cell Lymphoma.
- Breast CancerMr. Stunnenberg isExperienced. Learn about Breast Cancer.
- Breast Cancer in MenMr. Stunnenberg isExperienced. Learn about Breast Cancer in Men.
- Burkitt LymphomaMr. Stunnenberg isExperienced. Learn about Burkitt Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Mr. Stunnenberg isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).